GPR160 and prostate carcinoma: The targets identified based on the integrated analysis of CSMA data and publicly available transcriptomics data displayed high context specificity suggesting GPR160 and NPY likely to be the two most important GPCRs impacting on growth of human prostate and specifically prostate cancer cells.